» Articles » PMID: 17060974

HIV Evolution and Escape

Overview
Date 2006 Oct 25
PMID 17060974
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV) exemplifies the principles of Darwinian evolution with a telescoped chronology. Because of its high mutation rate and remarkably high rates of replication, evolution can be appreciated over periods of days in contrast to the durations conceived of by Darwin. Certain selective pressures that drive the evolution of HIV include chemotherapy, anatomic compartmentalization and the immune response. Examples of these selective forces on HIV evolution are described.

Citing Articles

A fundamental and theoretical framework for mutation interactions and epistasis.

Giacoletto C, Benjamin R, Rotter J, Schiller M Genomics. 2024; 116(6):110963.

PMID: 39561884 PMC: 11752442. DOI: 10.1016/j.ygeno.2024.110963.


PRESIDENT'S ADDRESS: VIROLOGY THROUGH THE LENS OF THE AMERICAN CLINICAL AND CLIMATOLOGICAL ASSOCIATION.

Howley P Trans Am Clin Climatol Assoc. 2023; 133:1-10.

PMID: 37701605 PMC: 10493715.


Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Zhang C, Otjengerdes R, Roewe J, Mejias R, Marschall A BioDrugs. 2020; 34(4):435-462.

PMID: 32301049 PMC: 7391400. DOI: 10.1007/s40259-020-00419-w.


Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.

Liu L, Dong A, Liao L, Feng Y, Shao Y, Liang S Curr HIV Res. 2019; 17(6):441-451.

PMID: 31778107 PMC: 7497539. DOI: 10.2174/1570162X17666191128101426.


Epistasis and entrenchment of drug resistance in HIV-1 subtype B.

Biswas A, Haldane A, Arnold E, Levy R Elife. 2019; 8.

PMID: 31591964 PMC: 6783267. DOI: 10.7554/eLife.50524.


References
1.
Poss M, Rodrigo A, Gosink J, Learn G, de Vange Panteleeff D, Martin Jr H . Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol. 1998; 72(10):8240-51. PMC: 110179. DOI: 10.1128/JVI.72.10.8240-8251.1998. View

2.
Mansky L, Temin H . Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995; 69(8):5087-94. PMC: 189326. DOI: 10.1128/JVI.69.8.5087-5094.1995. View

3.
Srinivasakumar N, Chazal N, Prasad S, Hammarskjold M, Rekosh D . The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J Virol. 1997; 71(8):5841-8. PMC: 191839. DOI: 10.1128/JVI.71.8.5841-5848.1997. View

4.
Drake J . Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A. 1993; 90(9):4171-5. PMC: 46468. DOI: 10.1073/pnas.90.9.4171. View

5.
Richman D . The implications of drug resistance for strategies of combination antiviral chemotherapy. Antiviral Res. 1996; 29(1):31-3. DOI: 10.1016/0166-3542(95)00911-6. View